Cellebrite Shares Decline in Premarket Trading Despite Q1 Earnings Beat
Despite reporting first-quarter earnings and revenue that exceeded analyst expectations, Cellebrite's shares fell more than 4% in premarket trading due to a weaker-than-expected second-quarter outlook. The company reported strong adjusted EPS of $0.12 and revenue growth of 19%, but investors reacted negatively to its guidance for slower Q2 revenue growth.
Tickers: $CLBT